Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 1
1948 2
1949 1
1950 3
1951 5
1952 4
1953 2
1954 9
1955 1
1956 4
1957 10
1958 2
1959 1
1960 12
1961 16
1962 24
1963 17
1964 21
1965 23
1968 14
1969 6
1970 18
1971 239
1972 446
1973 528
1974 759
1975 709
1976 728
1977 849
1978 1024
1979 1364
1980 1728
1981 2073
1982 2647
1983 3175
1984 4209
1985 4709
1986 5339
1987 6423
1988 7980
1989 10190
1990 13795
1991 16354
1992 19802
1993 23737
1994 27767
1995 30914
1996 26420
1997 18264
1998 18880
1999 19905
2000 20609
2001 20471
2002 20497
2003 22315
2004 23259
2005 23782
2006 23520
2007 23906
2008 23183
2009 23032
2010 24135
2011 25859
2012 26665
2013 25108
2014 24987
2015 22924
2016 20735
2017 18655
2018 17109
2019 8672
2020 147
Text availability
Article attribute
Article type
Publication date

Search Results

667,041 results
Results by year
Filters applied: . Clear all
Page 1
Enhancer talk
Snetkova V and Skok JA. Epigenomics 2018 - Review. PMID 29583027 Free PMC article.
Learning the sequence determinants of alternative splicing from millions of random sequences.
Rosenberg AB, et al. Cell 2015. PMID 26496609 Free article.
Toward better modeling the sequence determinants of alternative splicing, we measured the splicing patterns of over two million (M) synthetic mini-genes, which include degenerate subsequences totaling over 100 M bases of variation. ...Our results show that the vast majority of hexamer sequence motifs measurably influence splice site selection when positioned within alternative exons, with multiple motifs acting additively rather than cooperatively. ...
Toward better modeling the sequence determinants of alternative splicing, we measured the splicing patterns of over two million (M) s …
Turning up the Heat with Therapeutic Epigenome Editing
Zezulin A and Musunuru K. Cell Stem Cell 2018. PMID 29304336 Free article.
In the latest issue of Cell, Liao et al. (2017) show that a modified version of CRISPR-Cas9 can target and activate key therapeutic genes in vivo without altering DNA sequence identity....
In the latest issue of Cell, Liao et al. (2017) show that a modified version of CRISPR-Cas9 can target and activate key therapeutic genes in …
667,041 results
Jump to page
Feedback